Ignite Creation Date:
2024-05-05 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00435058
Status:
COMPLETED
Last Update Posted:
2007-02-19
First Post:
2007-02-12
Brief Title:
Visual Function Changes After Intraocular Pressure Reduction
Sponsor:
University of Sao Paulo
Organization:
University of Sao Paulo
Study Overview
Official Title:
Visual Function Changes After Intraocular Pressure Reduction Using Antiglaucoma Medications A Randomized Clinical Trial
Status:
COMPLETED
Status Verified Date:
2007-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
During the glaucomatous disease process subpopulations of cells may be dead damaged or healthy Visual function changes could be observed due to a recovering of the suffering ganglion cells after the intraocular pressure reduction This study aims at evaluating the correlation between intraocular pressure reduction and visual function changes in glaucoma patients after using antiglaucoma medications
Detailed Description:
Primary open angle glaucoma patients without use of antiglaucoma medications will be enrolled in this study After inclusion the patients will randomly receive one of three antiglaucoma medications timolol maleate 05 brimonidine tartrate 02 or travoprost 0004 in one randomly selected eye
The patients will be evaluated with Goldmann applanation tonometry visual acuity test contrast sensitivity test visual quality perception test visual analogue scale and standard automated perimetry before and after 4 weeks of glaucoma treatment onset
The patients will be evaluated with Goldmann applanation tonometry visual acuity test contrast sensitivity test visual quality perception test visual analogue scale and standard automated perimetry before and after 4 weeks of glaucoma treatment onset
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None